Hudson River Biotechnology Secures Major Funding from Oost NL and Eurogenetic

• Hudson River Biotechnology, an agricultural biotech company based in Wageningen, Netherlands, secures funding from Oost NL and Eurogenetic.
• The investment will support the company in scaling up commercially and advancing its technology for new products and services.
• Led by CEO Ferdinand Los, the company uses CRISPR technology to develop new crops with enhanced properties like higher yield and improved nutritional content.
• The European Parliament’s relaxation of regulations on genetic techniques like CRISPR is a significant milestone for global acceptance.
• With 30 employees, Hudson River Biotechnology collaborates with various institutions in the Food Valley region and receives support from Oost NL for its innovative plant improvement technologies.

Hudson River Biotechnology Secures Funding from Oost NL and Eurogenetic

Hudson River Biotechnology, a Wageningen, Netherlands-based agricultural biotech company, recently made headlines by securing funding from Oost NL and Eurogenetic. This investment marks a significant milestone for the company, as it paves the way for scaling up commercially and advancing their innovative technology. The collaboration with Oost NL and Eurogenetic signifies a strategic partnership that will propel Hudson River Biotechnology towards international growth and development. Ferdinand Los, the CEO of the company, expressed his enthusiasm about the investment, stating that it will not only support commercial expansion but also drive the creation of new products and services.

Revolutionizing Agriculture through CRISPR Technology

Led by Ferdinand Los, Hudson River Biotechnology specializes in developing new crops for the seed breeding industry using CRISPR technology. This cutting-edge approach involves precise molecular adjustments to the genetic code of crops, allowing for targeted modifications to enhance various plant properties. The application of CRISPR technology can lead to improvements in crop yield, nutritional content, and shelf life, revolutionizing the agricultural sector with its precision and efficiency. The recent investment from Oost NL and Eurogenetic will further empower Hudson River Biotechnology to harness the full potential of CRISPR technology and drive innovation in agriculture.

European Parliament’s Support for Genetic Techniques

The European Parliament’s decision to relax regulations on new genetic techniques, including CRISPR, represents a crucial milestone for companies like Hudson River Biotechnology. This regulatory shift distinguishes between traditional GMO crops, which incorporate transgenic DNA and are subject to market restrictions, and next-generation CRISPR crops, which do not contain transgenic DNA. Ferdinand Los views this regulatory change as a significant step forward, emphasizing the safety and control offered by CRISPR technology in developing future plant varieties. With Europe’s endorsement of CRISPR technology, Hudson River Biotechnology is well-positioned to lead the way in sustainable and innovative agriculture practices.

Related Video

Published on: March 2, 2021 Description: HRB is a biotech company offering end-to-end genome editing solutions for crops. We use our proprietary molecular breeding ...

Hudson River Biotechnology - Plant Genomics & Gene Editing Congress: USA

Collaborative Ecosystem for Agricultural Innovation

Hudson River Biotechnology’s success is deeply rooted in its collaborative ecosystem, which includes partnerships with leading institutions such as StartLife, Wageningen UR, Radboud University, and the University of Twente. By leveraging the expertise and resources of these academic and research organizations in the Food Valley region, the company has been able to drive continuous innovation and growth in the agricultural biotech sector. Oost NL’s support as a regional development agency further strengthens Hudson River Biotechnology’s position in the market, enabling them to pioneer advancements in plant improvements and contribute to long-term food security.

Hudson River Biotechnology’s recent funding acquisition from Oost NL and Eurogenetic underscores its commitment to driving agricultural innovation through CRISPR technology. With a focus on sustainable food production and technological advancements, the company is well-positioned to shape the future of agriculture and contribute to global food security. As Hudson River Biotechnology continues to expand its commercial operations and research initiatives, it stands as a beacon of innovation in the agricultural biotech landscape, poised to make a lasting impact on the industry.